A Randomized, Double-Blinded, Placebo-Controlled, Multiple-Dose, Safety and Pharmacokinetic Study of Ascending Doses of Oral CB-183,315 in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2016
At a glance
- Drugs Surotomycin (Primary)
- Indications Clostridium infections; Diarrhoea
- Focus Adverse reactions
- Sponsors Cubist Pharmaceuticals
- 26 Jan 2010 New trial record.